Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Patron Exim's Other Operating Expense for the
six
months ended in Mar. 2026 was ₹1.3 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2.9 Mil.
Patron Exim's quarterly Other Operating Expense
declined
from Mar. 2025 (₹35.3 Mil) to Sep. 2025 (₹1.6 Mil) and
declined
from Sep. 2025 (₹1.6 Mil) to Mar. 2026 (₹1.3 Mil).
Patron Exim's annual Other Operating Expense
increased
from Mar. 2024 (₹1.9 Mil) to Mar. 2025 (₹2.6 Mil) and
increased
from Mar. 2025 (₹2.6 Mil) to Mar. 2026 (₹2.9 Mil).
Patron Exim Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Patron Exim's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹2.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of ₹2.9 Mil mean?
Patron Exim (BOM:543798) has a Other Operating Expense of ₹2.9 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Patron Exim and its competitors.
Is Patron Exim's Other Operating Expense too high?
Patron Exim's current Other Operating Expense is ₹2.9 Mil. Overall, Patron Exim has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Patron Exim's Other Operating Expense compare to DOW?
Patron Exim's Other Operating Expense of ₹2.9 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Chemicals company?
A good Other Operating Expense depends on the Chemicals industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Patron Exim and its competitors. Patron Exim's current Other Operating Expense is ₹2.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Patron Exim stock overvalued right now?
Based on GuruFocus' analysis, Patron Exim (BOM:543798) is currently considered Possible Value Trap. The stock's GF Value™ is ₹26.24, compared to a current price of ₹2.10 — trading 92% below its estimated fair value. The current Other Operating Expense is ₹2.9 Mil. Patron Exim's overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Patron Exim (BOM:543798), the current Other Operating Expense is ₹2.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Patron Exim (BOM:543798) Overvalued in 2026?
Based on GuruFocus' analysis, Patron Exim stock appears to be undervalued.
The current stock price of ₹2.10 is trading 92% below its estimated GF Value™ of ₹26.24.
GuruFocus considers Patron Exim to be Possible Value Trap.
Key valuation signals for BOM:543798:
Other Operating Expense: ₹2.9 Mil
GF Value™: ₹26.24 vs. price of ₹2.10 (92% below fair value)
No single metric tells the full story. See the BOM:543798 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Patron Exim Ltd is engaged in the trading and distribution of pharmaceutical raw material, which is also known as APIs (Active Pharmaceutical Ingredients), industrial, excipient and solvents. Its product portfolio comprises of around 150 AIPs, Excipient, Pharma Chemical & Intermediates. It is also in the trading of a variety of chemicals, such as Petrochemicals, Dyes & Pigment Chemicals, Paints & Speciality Chemical, Agro Chemicals, Oil & Refinery Chemicals, Foam & Adhesive, Plywood & Laminates Chemical. The Chemicals also include food industry & water treatment chemicals, resins & plastics chemicals, polymers and additives etc. The Company is mainly dealing in Pharmaceutical Business i.e. trading of pharma products and commission agent in pharma products etc.
63GF Score
Get the complete analysis for BOM:543798
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543798 has been successfully added to your 
